CAS 914382-60-8

Tefinostat

CAS : 914382-60-8

Tefinostat

Degré de pureté : ≥98%

Masse moléculaire : 495.61g/mol

Ref: 54-BUP05323

Tefinostat

CAS : 914382-60-8

Tefinostat is a histone deacetylase inhibitor. It is used to treat cancer and has been shown to be effective against monocytic leukemia cells, HL-60 cells. Tefinostat has synergistic effects with certain growth factors in cell culture and also enhances the anticancer activity of other drugs such as tamoxifen. Tefinostat has been approved for use in women with breast cancer who are at high risk for recurrence or who have not responded to other therapies. This drug has been found to be well tolerated in clinical trials, but may cause headache, nausea, diarrhea, and fatigue.

Formule : C₂₈H₃₇N₃O₅

Degré de pureté : Min. 95%

Masse moléculaire : 495.6 g/mol

Ref: 3D-PLB38260

Tefinostat

CAS : 914382-60-8

Tefinostat (CHR-2845) is a potent monocyte/macrophage-targeted histone deacetylase (HDAC) inhibitor.

Formule : C₂₈H₃₇N₃O₅

Degré de pureté : 99.83%

Couleur et forme : Solid

Masse moléculaire : 495.61

Ref: TM-T17028